Showing 1951-1960 of 2050 results for "".
- Santen Announces Topline Data for DE-128 (MicroShunt) Demonstrating Reductions in IOP and Medication Use in Patients With Glaucomahttps://modernod.com/news/santen-announces-topline-data-for-de-128-microshunt-demonstrating-reductions-in-iop-and-medication-use-in-patients-with-glaucoma/2476840/Santen Pharmaceutical announced the results of INN-005, a prospective, randomized, controlled, single-masked, multicenter study to assess the safety and effectiveness of DE-128 (MicroShunt) standalone, without concomitant cataract extraction. The study compared DE-128 implanted intraoperatively w
- Lenstec Completes FDA Trial for SBL-3 IOLhttps://modernod.com/news/lenstec-completes-fda-trial-for-sbl-3-iol/2476837/Lenstec announced that it has completed its FDA trial for the SBL-3 IOL (Segmented Bifocal Lens), an asymmetric multifocal refractive IOL designed to provide patients with superior near, intermediate, and distance vision. It also offers improved contrast sensitivity and minimizes halos and glare
- Oklahoma Judge Orders Johnson & Johnson to Pay $572 Million in Bellwether Opioid Casehttps://modernod.com/news/oklahoma-judge-orders-johnson-johnson-to-pay-572-million-in-bellwether-opioid-case/2476824/A US judge has ruled that Johnson & Johnson must pay $572 million for contributing to an opioid crisis in Oklahoma, where the state’s attorney general had been seeking damages of more than $17 billion. District court Judge Thad Balkman said “the state met its burden that
- VSY Biotechnology’s Rotaryjet Preloaded Injector Has Been Registered by the European Patent Institutehttps://modernod.com/news/vsy-biotechnologys-rotaryjet-preloaded-injector-has-been-registered-by-the-european-patent-institute/2476820/VSY Biotechnology’s invention, the Rotaryjet Preloaded Injector containing an accessory system for the storage and injection of an IOL, has been registered by the European Patent Institute (EPI). This newly patented technology minimizes the use of viscoelastic material in IOL implantation and pro
- New World Medical Launches Ahmed ClearPath Glaucoma Drainage Devicehttps://modernod.com/news/new-world-medical-launches-ahmed-clearpath-glaucoma-drainage-device/2476814/New World Medical announced the launch of the Ahmed ClearPath glaucoma drainage device, which is available in two sizes, 350 mm2 and 250 mm.2 A unique feature of the Ahmed ClearPath implant is a flexible plate with a contour that closely conforms to the curvature of the eye
- Maui Jim and VSP Global Expand Relationship to Include Maui Jim Inside the VSP Formularyhttps://modernod.com/news/maui-jim-and-vsp-global-expand-relationship-to-include-maui-jim-inside-the-vsp-formulary/2479547/Maui Jim, the sunglass and eyewear supplier, announced “a significant step forward in its ongoing relationship with VSP Global,” reporting that Maui Jim will officially be available within the VSP formulary and will be included in the VSP contract lab network, according to a VisionMon
- Regenxbio Reports Additional Positive Interim Phase 1/2a Trial Update for RGX-314 for the Treatment of Wet AMDhttps://modernod.com/news/regenxbio-reports-additional-positive-interim-phase-1-2a-trial-update-for-rgx-314-for-the-treatment-of-wet-amd/2476800/As part of its quarterly results reporting, Regenxbio provided an update on its phase 1/2a for RGX-314 for the treatment of wet AMD. “We are encouraged by the continued positive interim data from the phase 1/2a RGX-314 trial and the potential of NAV gene therapy as a one-time treatm
- TopiVert Announces Topline Results from Phase 2b/3 Study of Dry Eye Disease Drug Candidatehttps://modernod.com/news/topivert-announces-topline-results-from-theia-1-phase-2b-3-clinical-study-of-top1630-as-a-treatment-for-dry-eye-disease/2476792/TopiVert Pharma announced topline results from THEIA-1 phase 2b/3 clinical study evaluating TOP1630, a novel anti-inflammatory kinase inhibitor, as an ophthalmic solution for the treatment of dry eye disease. THEIA-1, a multicenter, randomized, double-masked, placebo-controlled phase 2b/3
- VSY Biotechnology’s Rotaryjet Preloaded Injector Registered by the European Patent Institutehttps://modernod.com/news/vsy-biotechnologys-rotaryjet-preloaded-injector-registered-by-the-european-patent-institute/2476791/VSY Biotechnology’s Rotaryjet Preloaded Injector, which contains an accessory system for the storage and injection of an IOL, has been registered by the European Patent Institute (EPI). This newly patented technology minimizes the use of viscoelastic material in IOL implantation. The featu
- EssilorLuxottica, Maker of Ray-Ban Sunglasses, Agrees to Buy GrandVision in $8 Billion Dealhttps://modernod.com/news/ray-ban-maker-agrees-to-buy-grandvision-for-8-billion/2479558/A blockbuster deal in the eyecare retail space was announced on Wednesday as EssilorLuxottica, the maker of Ray-Ban sunglasses, agreed to buy Dutch retailer GrandVision NV in multi-billion dollar deal. Paris-based EssilorLuxottica agreed to buy control (77%) of European rival GrandVision f